Park City, UT

3 days / 6 sessions
Current Issues in Spine

February 2-4, 2017

Nexxt Spine Announces Full Market Release of INERTIA CORTI-FIXX™ Cortical-Cancellous Pedicle Screw System

April 27, 2017 by OrthoSpineNews
AAEAAQAAAAAAAAejAAAAJGRjYjhjYzg5LWYxZGUtNDc4My04MWVmLTY0ZDM4Y2NlNmJiYQ-1.png

April 26, 2017

NOBLESVILLE, Ind.–(BUSINESS WIRE)–Nexxt Spine, LLC, a medical device company focused on designing, manufacturing and distributing innovative spinal solutions, today announced the full market release of the INERTIA CORTI-FIXX™ Cortical-Cancellous Pedicle Screw System. Corti-Fixx screws are designed to achieve greater cortical bone purchase with a smaller midline incision when utilized in a medial to lateral pedicle approach known as the Cortical Bone Trajectory (CBT).

Corti-Fixx implants and instruments are built upon the Inertia Pedicle Screw System’s foundation and offer an alternative to traditional pedicle screw fixation. The unique dual to quad lead threads double the number of screw-to-bone contact points within the pedicle thereby increasing resistance to pull out.

Andy Elsbury, President of Nexxt Spine, stated, “Trends within the spine market call for less invasive procedures that are simple, reliable and reproducible. The Corti-Fixx screw further differentiates the Inertia Pedicle Screw System and provides multiple solutions for fixation in diminished bone quality through an open or MIS approach.”

About Nexxt Spine

Nexxt Spine, LLC is a privately held medical device manufacturer dedicated to increasing procedural efficiency and patient outcomes through development of innovative products, manufactured on the most technologically advanced platforms, and utilizing irreproachable quality standards to treat painful and debilitating spinal pathologies.

Additional information can be found at www.nexxtspine.com.

Contacts

Nexxt Spine, LLC
Sarah Koch, 317-436-7801
SKoch@NexxtSpine.com

OrthoSpineNews

OrthoSpineNews.com is the preferred aggregator of all news in the orthopedic and spine industry. You can subscribe for our daily email, follow us on twitter or download our app for iPhone and Android.